BIYKEM BOZKURT to Losartan
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Losartan.
Connection Strength
0.457
-
Losartan and prednisolone for post-COVID syndrome and cardiac inflammation: a randomized, double-blind, placebo-controlled trial. Nat Commun. 2026 07 30; 17(1).
Score: 0.242
-
Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints. J Cardiovasc Magn Reson. 2025; 27(1):101121.
Score: 0.215